Безопасен ли zinc palmitoyl nonapeptide-14 при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
Pregnancy-safe products containing zinc palmitoyl nonapeptide-14










Related ingredients
Frequently asked questions
- Безопасен ли zinc palmitoyl nonapeptide-14 при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
- Безопасен ли zinc palmitoyl nonapeptide-14 при грудном вскармливании?
- No evidence of reproductive or lactation-specific hazards from SCCS/CIR/ECHA or peer-reviewed literature for this ingredient. Dermal absorption is expected to be negligible for a large, palmitoylated peptide; therefore systemic exposure sufficient to reach breastmilk is not supported by available regulatory sources (no ECHA harmonised hazard, no CIR or SCCS contraindication).
- Безопасен ли zinc palmitoyl nonapeptide-14 для кожи малыша?
- No data indicating intrinsic developmental or reproductive hazard in infants. Mechanistic data are absent. Although adult dermal absorption is expected to be negligible, infant skin has higher surface-area-to-weight and an immature barrier; per the scoring guidance, exposure score is increased by +1 relative to adult (from 0 to 1) in the absence of evidence of complete non-absorbability. No infant-specific adverse data were found in the searched regulatory sources.
- Как VeriMom оценивает zinc palmitoyl nonapeptide-14?
- VeriMom оценивает zinc palmitoyl nonapeptide-14 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы zinc palmitoyl nonapeptide-14 при беременности?
- См. наш список безопасных альтернатив zinc palmitoyl nonapeptide-14 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.